Immunotherapie and Immunology news
Stem cell therapy holds immense promise for treating rare diseases in children, offering hope for conditions that are often difficult to manage with conventional treatments. Mesenchymal stem cells (MSCs) are particularly valuable in pediatric applications due to their safety and regenerative potential, addressing disorders like cerebral palsy, muscular dystrophy, and genetic conditions. This article explores […]
Read More »Researchers have discovered that IL1 promotes the clonal expansion of TET2 knockout cells in blood, enhancing their self-renewal and myeloid bias, which is linked to an increased risk of leukemia and cardiovascular disease.
Read More »CD34 protein is a transmembrane glycoprotein that is expressed on the surface of hematopoietic stem and progenitor cells (HSPCs). This protein plays a significant role in the regulation of cell adhesion, migration, and differentiation. CD34 protein is a crucial biomarker that is widely used to isolate and purify HSPCs for clinical applications such as hematopoietic […]
Read More »